Literature DB >> 8018328

Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous carcinoma cell lines.

K Pekkola-Heino1, H Joensuu, P Klemi, R Grenman.   

Abstract

OBJECTIVE: According to some clinical reports, DNA aneuploidy of squamous cell carcinomas is related to a more favorable response to radiotherapy than DNA diploidy, but it is not known whether this depends on differences in intrinsic cellular radiation sensitivity or on other factors involved during the course of radiotherapy.
DESIGN: Using flow cytometry, we analyzed 30 newly established squamous carcinoma cell lines derived from head and neck carcinoma, and compared the nuclear DNA content with the inherent radiosensitivity and with the average doubling time determined from the in vitro growth curves.
RESULTS: The nuclear DNA content expressed as the ratio between the Go/G1 peak of the cell line and the peak formed by chicken red blood cells varied from 3.13 to 6.41. The DNA content of cells obtained from nonmalignant lesions by fine-needle aspiration biopsy was from 2.66 to 2.80. No correlation was found between the nuclear DNA content and the inherent radiosensitivity of the carcinoma cells.
CONCLUSIONS: The result suggests that the intrinsic cellular radiosensitivity of carcinomas does not increase in parallel with an increasing nuclear DNA content. Nor does the in vitro proliferation rate associate with either the nuclear DNA content or inherent radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018328     DOI: 10.1001/archotol.1994.01880310054010

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  Differential proliferation dependence of alpha and beta damage in X-irradiated Chinese hamster cells.

Authors:  D Bartkowiak; W Nothdurft; E M Röttinger
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

2.  DNA ploidy and protein synthesis in squamous cell carcinoma cell lines of the head and neck.

Authors:  T Görögh; B M Lippert; E Sprenger; S Saffran; K Heidorn; G Bergmann; E Henze; J A Werner
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Broccoli extract improves chemotherapeutic drug efficacy against head-neck squamous cell carcinomas.

Authors:  Osama A Elkashty; Ramy Ashry; Ghada Abu Elghanam; Hieu M Pham; Xinyun Su; Camille Stegen; Simon D Tran
Journal:  Med Oncol       Date:  2018-08-04       Impact factor: 3.064

4.  Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma.

Authors:  K Pekkola-Heino; M Jaakkola; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 5.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

6.  Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.

Authors:  Zhixiang Wu; Jessica B Doondeea; Amin Moghaddas Gholami; Melanie C Janning; Simone Lemeer; Karl Kramer; Suzanne A Eccles; Susanne M Gollin; Reidar Grenman; Axel Walch; Stephan M Feller; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2011-09-28       Impact factor: 5.911

7.  The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.

Authors:  T Björk-Eriksson; C M West; E Cvetskovska; M Svensson; E Karlsson; B Magnusson; N J Slevin; S Edström; C Mercke
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

8.  Lysosomal trapping of palbociclib and its functional implications.

Authors:  Susana Llanos; Diego Megias; Carmen Blanco-Aparicio; Elena Hernández-Encinas; Miguel Rovira; Federico Pietrocola; Manuel Serrano
Journal:  Oncogene       Date:  2019-01-28       Impact factor: 9.867

9.  Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers.

Authors:  Susana Llanos; Juana M García-Pedrero; Lucia Morgado-Palacin; Juan P Rodrigo; Manuel Serrano
Journal:  Nat Commun       Date:  2016-02-02       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.